Latest News
Intellia Therapeutics, Inc.
- Intellia Therapeutics, Inc. Estimates – GETTEX:38I
- Intellia Therapeutics names Jing Marantz as EVP and CMO
- Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
- Intellia Therapeutics names Jing Marantz as chief medical officer
- Intellia Therapeutics names Jing Marantz as chief medical officer By Investing.com
- Intellia Therapeutics names Jing L. Marantz as new Chief Medical Officer to lead clinical and regulatory efforts.
- Intellia Therapeutics Q2 2026 Earnings Call Transcript
- Cathie Wood's Ark Invest weekly recap: loads up on Nvidia, Intellia; pares AMD
- Cathie Wood’s ARK buys Intellia stock, sells Alphabet shares
- Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
- No-Moat Intellia Therapeutics Provides Pure-Play, Long-Term Exposure to Gene Editing Therapies
- Intellia Therapeutics Bears Growl Again, This Time About Claude AI -- Yawn! (NASDAQ:NTLA)
Headlines from the last 30 days, linking to the original publishers. See all market news →